American College of Cardiology
@accintouch.bsky.social
Official American College of Cardiology account. Join us to transform cardiovascular care & improve heart health for all 🫀🩺🌎| ACC.org.
We're equipping cardiologists, surgeons and CV researchers with the skills to lead and make a difference in clinical research through the year-long Clinical Trials Research Program.
📆Application Closes Dec. 5
🔎Structural #HeartDisease & #cvEP Tracks
🔗 https://bit.ly/43vUtYt
#EPeeps #CardioSky
📆Application Closes Dec. 5
🔎Structural #HeartDisease & #cvEP Tracks
🔗 https://bit.ly/43vUtYt
#EPeeps #CardioSky
November 15, 2025 at 8:54 PM
We're equipping cardiologists, surgeons and CV researchers with the skills to lead and make a difference in clinical research through the year-long Clinical Trials Research Program.
📆Application Closes Dec. 5
🔎Structural #HeartDisease & #cvEP Tracks
🔗 https://bit.ly/43vUtYt
#EPeeps #CardioSky
📆Application Closes Dec. 5
🔎Structural #HeartDisease & #cvEP Tracks
🔗 https://bit.ly/43vUtYt
#EPeeps #CardioSky
ACC's October Board of Trustees meeting was rich with strategic dialogue and forward-looking initiatives.
🌟 Highlights include:
✅ New #ACCIntl Chapters
✅ Clinical Guidance Documents
✅ Focus on Philanthropy
➕ More!
Check out the highlights: 🔗 https://bit.ly/3LDPoYf #ACCBOT #CardioSky #MedSky
🌟 Highlights include:
✅ New #ACCIntl Chapters
✅ Clinical Guidance Documents
✅ Focus on Philanthropy
➕ More!
Check out the highlights: 🔗 https://bit.ly/3LDPoYf #ACCBOT #CardioSky #MedSky
November 13, 2025 at 9:15 PM
ACC's October Board of Trustees meeting was rich with strategic dialogue and forward-looking initiatives.
🌟 Highlights include:
✅ New #ACCIntl Chapters
✅ Clinical Guidance Documents
✅ Focus on Philanthropy
➕ More!
Check out the highlights: 🔗 https://bit.ly/3LDPoYf #ACCBOT #CardioSky #MedSky
🌟 Highlights include:
✅ New #ACCIntl Chapters
✅ Clinical Guidance Documents
✅ Focus on Philanthropy
➕ More!
Check out the highlights: 🔗 https://bit.ly/3LDPoYf #ACCBOT #CardioSky #MedSky
The heart of #ACC26 is missing a piece… it could be YOUR idea! 🧩
Help us create one final session for ACC.26. What topics did you miss learning about this year?
Submit your idea now and help shape the conversation! ↪️ http://bit.ly/4owX90K
#CardioSky #MedSky
Help us create one final session for ACC.26. What topics did you miss learning about this year?
Submit your idea now and help shape the conversation! ↪️ http://bit.ly/4owX90K
#CardioSky #MedSky
November 12, 2025 at 9:25 PM
The heart of #ACC26 is missing a piece… it could be YOUR idea! 🧩
Help us create one final session for ACC.26. What topics did you miss learning about this year?
Submit your idea now and help shape the conversation! ↪️ http://bit.ly/4owX90K
#CardioSky #MedSky
Help us create one final session for ACC.26. What topics did you miss learning about this year?
Submit your idea now and help shape the conversation! ↪️ http://bit.ly/4owX90K
#CardioSky #MedSky
Cardiology mentors please raise your hands ✋
Learn how you can shape the future of the field through strong mentorship like Dr. Contreras with the #ACCIMProgram ➕ Pediatric Residents Cardiology Programs! Apply by Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed #Cardiology #CardioSky
Learn how you can shape the future of the field through strong mentorship like Dr. Contreras with the #ACCIMProgram ➕ Pediatric Residents Cardiology Programs! Apply by Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed #Cardiology #CardioSky
November 12, 2025 at 4:52 PM
Cardiology mentors please raise your hands ✋
Learn how you can shape the future of the field through strong mentorship like Dr. Contreras with the #ACCIMProgram ➕ Pediatric Residents Cardiology Programs! Apply by Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed #Cardiology #CardioSky
Learn how you can shape the future of the field through strong mentorship like Dr. Contreras with the #ACCIMProgram ➕ Pediatric Residents Cardiology Programs! Apply by Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed #Cardiology #CardioSky
“Philanthropy can lead to some really remarkable changes in how leadership can be cultivated, research can be distributed and health care can be improved.” 🗣️ ACC Philanthropic Fundraising Committee Chair Dr. @jimjanuzzi.bsky.social
📽️ https://bit.ly/4qQrkBv #ACCPresident @chriskramermd.bsky.social
📽️ https://bit.ly/4qQrkBv #ACCPresident @chriskramermd.bsky.social
November 11, 2025 at 5:40 PM
“Philanthropy can lead to some really remarkable changes in how leadership can be cultivated, research can be distributed and health care can be improved.” 🗣️ ACC Philanthropic Fundraising Committee Chair Dr. @jimjanuzzi.bsky.social
📽️ https://bit.ly/4qQrkBv #ACCPresident @chriskramermd.bsky.social
📽️ https://bit.ly/4qQrkBv #ACCPresident @chriskramermd.bsky.social
Long-term melatonin use for insomnia was associated w/ a higher hazard of #heartfailure, an ↗️ in HF hospitalizations & a doubling of all-cause mortality over 5️⃣ years, according to a large, multinational cohort study presented at #AHA25.
More: https://bit.ly/43qUn4B #CardioSky #MedSky
More: https://bit.ly/43qUn4B #CardioSky #MedSky
Research Suggests Long-Term Melatonin Use For Insomnia Increases HF Risk - American College of Cardiology
bit.ly
November 11, 2025 at 5:36 PM
Long-term melatonin use for insomnia was associated w/ a higher hazard of #heartfailure, an ↗️ in HF hospitalizations & a doubling of all-cause mortality over 5️⃣ years, according to a large, multinational cohort study presented at #AHA25.
More: https://bit.ly/43qUn4B #CardioSky #MedSky
More: https://bit.ly/43qUn4B #CardioSky #MedSky
📢 POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With #HFrEF
Read more: https://bit.ly/4hV9byv
#AHA25 #HeartFailure #CardioSky #MedSky
Read more: https://bit.ly/4hV9byv
#AHA25 #HeartFailure #CardioSky #MedSky
November 10, 2025 at 10:35 PM
📢 POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With #HFrEF
Read more: https://bit.ly/4hV9byv
#AHA25 #HeartFailure #CardioSky #MedSky
Read more: https://bit.ly/4hV9byv
#AHA25 #HeartFailure #CardioSky #MedSky
FOOD-HF shows promise: Food-as-Medicine improved QoL post-#HeartFailure discharge, though HF events remained unchanged.
Details from #AHA25: https://bit.ly/47QjFKE #CardioSky #MedSky
Details from #AHA25: https://bit.ly/47QjFKE #CardioSky #MedSky
November 10, 2025 at 6:50 PM
FOOD-HF shows promise: Food-as-Medicine improved QoL post-#HeartFailure discharge, though HF events remained unchanged.
Details from #AHA25: https://bit.ly/47QjFKE #CardioSky #MedSky
Details from #AHA25: https://bit.ly/47QjFKE #CardioSky #MedSky
Early Initiation of PSCK9 inhibition with alirocumab ➕ statin therapy safely lowered LDL-C in #Hearttx patients, but didn’t ⬇️ coronary artery plaque progression, based on CAVIAR findings presented at #AHA25.
Read more: https://bit.ly/444cwVZ
#HeartFailure #CardioSky #MedSky
Read more: https://bit.ly/444cwVZ
#HeartFailure #CardioSky #MedSky
November 10, 2025 at 5:55 PM
Early Initiation of PSCK9 inhibition with alirocumab ➕ statin therapy safely lowered LDL-C in #Hearttx patients, but didn’t ⬇️ coronary artery plaque progression, based on CAVIAR findings presented at #AHA25.
Read more: https://bit.ly/444cwVZ
#HeartFailure #CardioSky #MedSky
Read more: https://bit.ly/444cwVZ
#HeartFailure #CardioSky #MedSky
Stress CMR-guided #cvImaging in patients w/ chest pain & nonobstructive #cvCAD was superior to angiography only in correctly diagnosing microvascular angina & improving chest pain symptoms & QoL, based on findings from CorCMR trial presented at #AHA25. 🔗 https://bit.ly/4hRZ0dJ
November 10, 2025 at 3:30 PM
Stress CMR-guided #cvImaging in patients w/ chest pain & nonobstructive #cvCAD was superior to angiography only in correctly diagnosing microvascular angina & improving chest pain symptoms & QoL, based on findings from CorCMR trial presented at #AHA25. 🔗 https://bit.ly/4hRZ0dJ
TUXEDO-2 findings suggest a ticagrelor-based #DAPT regimen does not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based regimen.
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
November 10, 2025 at 3:10 PM
TUXEDO-2 findings suggest a ticagrelor-based #DAPT regimen does not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based regimen.
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky
CELEBRATE: Zalunfiban administered on first medical contact w/ suspected #STEMI patients was associated w/ improved patency of the infarct-related artery at index angiography and a significantly lower chance of MACE at 30 days.
Read more: https://bit.ly/47N6jyH
#AHA25 #CardioSky #MedSky
Read more: https://bit.ly/47N6jyH
#AHA25 #CardioSky #MedSky
November 10, 2025 at 2:31 PM
CELEBRATE: Zalunfiban administered on first medical contact w/ suspected #STEMI patients was associated w/ improved patency of the infarct-related artery at index angiography and a significantly lower chance of MACE at 30 days.
Read more: https://bit.ly/47N6jyH
#AHA25 #CardioSky #MedSky
Read more: https://bit.ly/47N6jyH
#AHA25 #CardioSky #MedSky
#AHA25: With ⬆️ BP continuing to be a 🌍 challenge, effective management must remain a global priority. The results from BETTER-BP 👇, GOFRESH & Healthy Family offer 3 strategies targeting behavior, diet & family that could inform larger-scale programs.
🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky
🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky
November 9, 2025 at 10:45 PM
#AHA25: With ⬆️ BP continuing to be a 🌍 challenge, effective management must remain a global priority. The results from BETTER-BP 👇, GOFRESH & Healthy Family offer 3 strategies targeting behavior, diet & family that could inform larger-scale programs.
🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky
🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky
Hear insights from #ACCPresident Christopher M. Kramer, MD, FACC, on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care.
Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social
Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social
November 9, 2025 at 6:59 PM
Hear insights from #ACCPresident Christopher M. Kramer, MD, FACC, on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care.
Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social
Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social
Does one cup a day keep #AFib away? ☕ Findings from DECAF show coffee is linked to lower recurrence after cardioversion.
Follow ACC's coverage of #AHA25 for more insights ➡️ https://bit.ly/4p2s1pD #CardioSky #MedSky
Follow ACC's coverage of #AHA25 for more insights ➡️ https://bit.ly/4p2s1pD #CardioSky #MedSky
November 9, 2025 at 4:05 PM
Does one cup a day keep #AFib away? ☕ Findings from DECAF show coffee is linked to lower recurrence after cardioversion.
Follow ACC's coverage of #AHA25 for more insights ➡️ https://bit.ly/4p2s1pD #CardioSky #MedSky
Follow ACC's coverage of #AHA25 for more insights ➡️ https://bit.ly/4p2s1pD #CardioSky #MedSky
DARE-AF & META-AF: Findings 🔎 on post-ablation strategies for patients w/ #AFib, including use of dapagliflozin in people w/out current indications for #SGLT2i & metformin compared w/ standard care in those w/ obesity/overweight but no #diabetes. https://bit.ly/4nJMbUc
#AHA25 #CardioSky #MedSky
#AHA25 #CardioSky #MedSky
November 9, 2025 at 3:47 PM
DARE-AF & META-AF: Findings 🔎 on post-ablation strategies for patients w/ #AFib, including use of dapagliflozin in people w/out current indications for #SGLT2i & metformin compared w/ standard care in those w/ obesity/overweight but no #diabetes. https://bit.ly/4nJMbUc
#AHA25 #CardioSky #MedSky
#AHA25 #CardioSky #MedSky
🎤 Your Voice, Your Session!
If you could design one session for #ACC26 that isn’t in the current program, what would it be?
👂 Tell us! We’re listening! Submit now ↪️ bit.ly/4owX90K
#AHA25 #CardioSky #MedSky
If you could design one session for #ACC26 that isn’t in the current program, what would it be?
👂 Tell us! We’re listening! Submit now ↪️ bit.ly/4owX90K
#AHA25 #CardioSky #MedSky
November 9, 2025 at 3:30 PM
🎤 Your Voice, Your Session!
If you could design one session for #ACC26 that isn’t in the current program, what would it be?
👂 Tell us! We’re listening! Submit now ↪️ bit.ly/4owX90K
#AHA25 #CardioSky #MedSky
If you could design one session for #ACC26 that isn’t in the current program, what would it be?
👂 Tell us! We’re listening! Submit now ↪️ bit.ly/4owX90K
#AHA25 #CardioSky #MedSky
TOP findings from #AHA25 found a liberal transfusion strategy did not reduce death or major ischemic outcome rates compared w/ a restrictive strategy in patients at ⬆️ risk of a cardiac event following major vascular or general surgery.
Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky
Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky
November 8, 2025 at 10:40 PM
TOP findings from #AHA25 found a liberal transfusion strategy did not reduce death or major ischemic outcome rates compared w/ a restrictive strategy in patients at ⬆️ risk of a cardiac event following major vascular or general surgery.
Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky
Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky
Studies like OCEAN from #AHA25 are reshaping strategies for managing #AFib, exploring topics like ongoing anticoagulation post-catheter ablation; optimal antithrombotic approaches after #cvPCI; and LAAC vs. medical therapy in high-risk patients.
More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky
More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky
November 8, 2025 at 9:30 PM
Studies like OCEAN from #AHA25 are reshaping strategies for managing #AFib, exploring topics like ongoing anticoagulation post-catheter ablation; optimal antithrombotic approaches after #cvPCI; and LAAC vs. medical therapy in high-risk patients.
More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky
More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky
MAPLE-HCM: Patients with oHCM treated with aficamten saw superior benefits in #heartfailure symptoms, exercise capacity, LVOT gradient and overall health status when compared to metoprolol.
Learn more: https://bit.ly/47wIVqD
#AHA25 #JACC #HCM #cvHCM #CardioSky #MedSky @jaccjournals.bsky.social
Learn more: https://bit.ly/47wIVqD
#AHA25 #JACC #HCM #cvHCM #CardioSky #MedSky @jaccjournals.bsky.social
November 8, 2025 at 8:40 PM
MAPLE-HCM: Patients with oHCM treated with aficamten saw superior benefits in #heartfailure symptoms, exercise capacity, LVOT gradient and overall health status when compared to metoprolol.
Learn more: https://bit.ly/47wIVqD
#AHA25 #JACC #HCM #cvHCM #CardioSky #MedSky @jaccjournals.bsky.social
Learn more: https://bit.ly/47wIVqD
#AHA25 #JACC #HCM #cvHCM #CardioSky #MedSky @jaccjournals.bsky.social
#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study.
Get the full details here: https://bit.ly/4oBNohQ
#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
Get the full details here: https://bit.ly/4oBNohQ
#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
November 8, 2025 at 7:51 PM
#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study.
Get the full details here: https://bit.ly/4oBNohQ
#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
Get the full details here: https://bit.ly/4oBNohQ
#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
VESALIUS-CV results show evolocumab reduced the risk of first cardiovascular events among patients with atherosclerosis or diabetes and without a previous #cvMI or #stroke compared with placebo.
Read more in our #AHA25 coverage: https://bit.ly/4oBNohQ
#CardioSky #MedSky
Read more in our #AHA25 coverage: https://bit.ly/4oBNohQ
#CardioSky #MedSky
November 8, 2025 at 4:15 PM
VESALIUS-CV results show evolocumab reduced the risk of first cardiovascular events among patients with atherosclerosis or diabetes and without a previous #cvMI or #stroke compared with placebo.
Read more in our #AHA25 coverage: https://bit.ly/4oBNohQ
#CardioSky #MedSky
Read more in our #AHA25 coverage: https://bit.ly/4oBNohQ
#CardioSky #MedSky
CRISPR-Cas9 ➡️ First-in-Human trial presented at #AHA25 suggests one-time infusion of an investigational CRISPR-Cas9 therapy targeting ANGPTL3 is safe & can reduce both LDL cholesterol & triglycerides.
Read the ACC News Story for more: https://bit.ly/47Nfb7O
#cvLipids #CardioSky #MedSky
Read the ACC News Story for more: https://bit.ly/47Nfb7O
#cvLipids #CardioSky #MedSky
November 8, 2025 at 3:30 PM
CRISPR-Cas9 ➡️ First-in-Human trial presented at #AHA25 suggests one-time infusion of an investigational CRISPR-Cas9 therapy targeting ANGPTL3 is safe & can reduce both LDL cholesterol & triglycerides.
Read the ACC News Story for more: https://bit.ly/47Nfb7O
#cvLipids #CardioSky #MedSky
Read the ACC News Story for more: https://bit.ly/47Nfb7O
#cvLipids #CardioSky #MedSky
2️⃣ late-breaking science presentations highlight new treatments for severe hypertriglyceridemia at #AHA25.
Read how the novel DR10624 medication reduced triglyceride levels ➕ liver fat, & about the benefits of olezarsen in ↘️ pancreatitis. 🔗 https://bit.ly/47xGfch
#CardioSky #MedSky
Read how the novel DR10624 medication reduced triglyceride levels ➕ liver fat, & about the benefits of olezarsen in ↘️ pancreatitis. 🔗 https://bit.ly/47xGfch
#CardioSky #MedSky
November 8, 2025 at 3:16 PM
2️⃣ late-breaking science presentations highlight new treatments for severe hypertriglyceridemia at #AHA25.
Read how the novel DR10624 medication reduced triglyceride levels ➕ liver fat, & about the benefits of olezarsen in ↘️ pancreatitis. 🔗 https://bit.ly/47xGfch
#CardioSky #MedSky
Read how the novel DR10624 medication reduced triglyceride levels ➕ liver fat, & about the benefits of olezarsen in ↘️ pancreatitis. 🔗 https://bit.ly/47xGfch
#CardioSky #MedSky
🆕 #JACC Leadership Page from #ACCPresident @chriskramermd.bsky.social and ACC leaders Drs. Malissa J. Wood and Sandra J. Lewis emphasize the value of intentional investment in leadership development ➕ non-clinical competencies.
Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky
Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky
November 7, 2025 at 10:00 PM
🆕 #JACC Leadership Page from #ACCPresident @chriskramermd.bsky.social and ACC leaders Drs. Malissa J. Wood and Sandra J. Lewis emphasize the value of intentional investment in leadership development ➕ non-clinical competencies.
Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky
Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky